Medindia

X

The Pharmaceutical Industry and the Election - New Report Available for Free From Decision Resources

Thursday, October 23, 2008 General News J E 4
Advertisement
WALTHAM, Mass., Oct. 22 Decision Resources, one of theworld's leading research and advisory firms focusing on pharmaceutical andhealthcare issues, has made available for free on their Web site a report thatdetails how key government activities are affecting the biopharmaceuticalindustry. The report entitled Pharma and the Feds: Key Government Activitiesand How They Affect the Biopharmaceutical Industry covers enacted and proposedlegislation in front of Congress including the Healthcare InformationTechnology Acts, stem cell research, Medicare Improvements for Patients andProviders Act of 2008 and much more.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081022/NEW021 )

A section in the report entitled "All Eyes on the White House" breaks downthe implications for pharma depending on which candidate makes it to officeand covers overall political trends relating to the pharma industry like thefact that pharma industry donations to Democratic candidates are outpacingthose to Republicans. This deviation (the pharma industry usually aligns withRepublicans) can be attributed to John McCain's support of several issues thatthe pharma industry opposes such as drug importation and biosimilars.

Also available to the media is a detailed figure entitled "DrugReimportation Timeline: Politics, Patient's Rights, and PharmaceuticalIndustry Lobbying." The figure displays major events from October 2001 throughNovember 2008 that are affecting drug reimportation. The figure is included inthis release, and media may contact Decision Resources for a higher resolutionif needed.

About Spectrum

Pharma and the Feds: Key Government Activities and How They Affect theBiopharmaceutical Industry is a special report from Spectrum, an executiveadvisory service that identifies and analyzes key business and technologydrivers of the pharmaceutical and biotechnology markets. Available onlythrough Decision Resources, Spectrum is a mix of publications and telephoneinquiry access to analysts that provides an "over the horizon" perspective oncomplex healthcare issues.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in marketresearch publications, advisory services and consulting designed to helpclients shape strategy, allocate resources and master their chosen markets.Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offersbest-in-class, high-value information and insights on important sectors of thehealthcare industry. Clients rely on this analysis and data to make informeddecisions. Please visit Decision Resources, Inc. atwww.DecisionResourcesInc.com.

All company, brand or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Natalia Morales Elizabeth Marshall Decision Resources Decision Resources, Inc. 781-296-2691 781-296-2563 nmorales@dresources.com emarshall@dresources.com

SOURCE Decision Resources
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mylan Receives Tentative FDA Approval for First-to...
S
Award-winning Health IT Innovator Enhanced Medical...